Novel Coronavirus 2019 is a new coronavirus strain not previously identified in humans. On February 11, 2020 the World Health Organization announced SARS-CoV-2 as the official name of the new virus responsible for the COVID-19 disease.
The virus that causes COVID-19 appears to spreading easily in the community in some affected areas. This is why CDC recommends isolating infected individuals until they no longer pose a risk of infecting others. The CDC states that coronaviruses commonly spread from person to person through close personal contact, in the air by coughing or sneezing, touching surfaces or objects with the virus on it and then touching your nose, mouth or eyes before washing your hands.
According to the CDC, the best way to prevent illness is to avoid being exposed to the virus. Take steps to protect yourself including:
If you are sick, stay home and get medical attention. Cover your sneezes and coughs and wear a face mask.
Clean and Disinfect frequently touched surfaces every day. Doorknobs, light switches, cell phones, keyboards and faucets are a few examples.
To disinfect, the CDC recommends a diluted household bleach solution, 70% alcohol or an EPA-registered product from List N Disinfectants for Use Against SARS-CoV-2.
PURE® Hard Surface (EPA Reg. No. 72977-5-73912) has been added to EPA’s List N: Disinfectants for Use Against SARS-CoV-2 based on its efficacy against the Human Coronavirus. The list is comprised of the primary product registration number and may be sold under a different brand name. You can identify the product by the three-part EPA Reg. No. The first two parts match the primary product and the third set of numbers represents the distributor ID. SDC3A (EPA Reg. No. 72977-5) is the primary product registered by the EPA and sold under brand name PURE Hard Surface.
When using PURE Hard Surface, follow the label instructions for disinfecting hard, non-porous surfaces against Human Coronavirus.EPA List N is located at https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2